Subscribe
eNewsletter
Ready to get certified?
Free CDCES Coach App
Download
Free Med Pocket Cards
eNewsletter
Free CDCES Coach App
Free Med Pocket Cards
What is the best way to dispose of expired medications or those that are no longer of use? October 26 (this Saturday!) is National Prescription Drug Take Back Day. Between … Continue reading National Prescription Drug Take Back Day this Saturday
Our Diabetes Detective Team scans the diabetes news to discover the most relevant info that Diabetes Educators need in their daily practice. We post one daily Blog Byte from Monday … Continue reading Question of the Week | October 22, 2019
James Keck, MD, set out to find if adult patients at an academic family medicine clinic, who were actively screened for prediabetes, received a referral to the Diabetes Prevention Program. … Continue reading Why such low MD referrals for National Diabetes Prevention Program?
Whether it’s the candy, the turkey, stuffing, or the desserts, the holidays are a difficult time for anyone to eat healthy and avoid weight gain. Experts suggest that the holidays … Continue reading Free Resource Friday | Navigating Holiday Festivities
A three-year long study showed real time continuous glucose monitoring (rtCGM) was associated with lower A1c levels in people with type 1 diabetes, whether the participants used pumps or multiple … Continue reading Continuous Glucose Monitoring – The key to improving BG?
Adverse Childhood Experiences (ACE) such as neglect, abuse, household dysfunction, etc. have been found to have a profound impact on health and disease throughout life. Here is the the link … Continue reading Adverse Childhood Experiences impact future health
Our Diabetes Detective Team scans the diabetes news to discover the most relevant info that Diabetes Educators need in their daily practice. We post one daily Blog Byte from Monday … Continue reading Question of the Week | October 15, 2019
Canagliflozin (Invokana), an SGLT-2 Inhibitor, just received a new Food and Drug Administration (FDA) indication. Adults with type 2 diabetes and diabetes kidney disease who take canagliflozin (Invokana) experience a … Continue reading Free Resource Friday | PocketCards Updated with new Canagliflozin Indication and Oral GLP-1